Deep knowledge on
small-molecule drugs and
the 90,000 global patents
|Title:||Medicinal aerosol formulations|
|Abstract:||A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.|
|Inventor(s):||Purewal; Tarlochan S. (Leamington Spa, GB2), Greenleaf; David J. (Loughborough, GB2)|
|Assignee:||Riker Laboratories, Inc. (St. Paul, MN)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Publication Date||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Spain||2077971||Dec 17, 2009|
|Hong Kong||7196||Jan 26, 1996|
|European Patent Office||0499344||Aug 19, 1992|
|Germany||68904300||Feb 18, 1993|
|New Zealand||231579||Nov 25, 1993|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.